Platform Group

The Platform Group has signed a financing agreement for up to €80 million, earmarked specifically for acquisition financing. The lenders are an internationally active financial group and a company affiliated with the main shareholder. Disbursement is subject to market-standard conditions precedent and complies with the terms of the existing bond. In 2025 the group generated revenue of €728 million and an adjusted EBITDA of €55 million. » More on finanzen.net

The Platform Group has agreed to acquire AEP GmbH and will take 100% of the shares; closing is expected after antitrust clearance in the second quarter of 2026. The pharma business will be bundled as a separate division, “Pharma & Service Goods”, and AEP will be consolidated together with ApoNow, apothekia and Doc.Green. Pro forma for 2026, TPG expects a GMV of €3.0 billion, revenue of €2 billion, EBITDA of €90–100 million and more than 25,000 partners. Financing will come from cash, equity and debt; two capital increases totaling 2 million shares raised €9.8 million, and the target leverage ratio is 1.5–2.3. » More on finanzen.net

On 29 August 2025, insider Bjoern Minnier purchased 990 The Platform Group shares at €10.10 each; the transaction was reported to BaFin on 3 September 2025. The stock reacted positively and rose in FSE trading, quoting €9.90 on the publication day after an earlier close of €9.68. Earlier, the closely related Benner Holding GmbH executed a proprietary trade of 50,000 papers at €9.50; market capitalization is about €199.68m. » More on finanzen.net